IRMD
iRadimed Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
iRadimed (IRMD) Stock: Buy, Sell, or Hold?
$86.72
-0.22 (-0.25%)
âŧ
5d:
+6.92%
30d:
-3.07%
90d:
-0.78%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (87%)
Quality Score
53/100
Position
FAIR
30-Day Fair Range
$83.06 â $89.00
Position: FAIR
Forward P/E & Valuation
35.6x
CHEAP
vs 40.0x historical avg
Wall Street Target
$118.00
+36.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$76.35 / $89.45
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: IRMD is fairly priced but lacks strong directional signals. At -3.9% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When IRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$98.18
Based on 10.1% avg growth
INTRINSIC VALUE TODAY
$60.96
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRMD is currently trading at $86.72, which is considered fair relative to its 30-day fair value range of $83.06 to $89.00. From a valuation perspective, the stock is trading at a discount (Forward PE: 35.6) compared to its historical average (40.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.9% over the next few years. This pessimistic expectation contrasts with the company's recent 18.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, IRMD is in a downtrend. Immediate support is located at $76.35, while resistance sits at $89.45.
Market Sentiment: IRMD scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.00 (+36.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IRMD is in a downtrend. Immediate support is located at $76.35, while resistance sits at $89.45.
Market Sentiment: IRMD scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $118.00 (+36.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$83.06 -
$89.00
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.5%
Trading Range & Key Levels
30-Day Trading Range
$83.06 -
$89.00
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$4.40
(5.1%)
Support Level
$76.35
Resistance Level
$89.45
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding IRMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.1% below Wall St target ($118.00)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
35.59
Wall Street Target
$118.00
(+36.1%)
Revenue Growth (YoY)
14.2%
Earnings Growth (YoY)
18.3%
Profit Margin
26.9%
Valuation Discount vs History
-3.9% cheaper
PE vs Historical
35.6 vs 40.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.9%
(market-implied from PE analysis)
1-Year Target
$83.34
(-4%)
2-Year Target
$80.09
(-8%)
3-Year Target
$76.96
(-11%)
3-Yr Target (if PE normalizes)
(PE: 36â40)
$86.50
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 35.6, Growth: 16.2%)
$136.12
(+57%)
Base:
(SPY PE: 19.9, Growth: 16.2%)
$75.96
(-12%)
Bear:
(PE: 16.9, Growth: 16.2%)
$64.57
(-26%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (46x PE), but valuation improves significantly next year (36x PE) as earnings recover.
Trailing PE: 46.49 | Current EPS (TTM): $1.87
Bull Case
$124.62
(+44%)
Analyst growth 30.3%, PE expands to 51.1
Base Case
$113.29
(+31%)
Market implied 30.3%, PE stable at 46.5
Bear Case
$59.12
(-32%)
Severe decline -20.0%, PE contracts to 39.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 35.6 to 40.0
Stabilization Target:
$97.47
(+12.4%)
PE Expansion Potential:
+12.4%
Share IRMD Analysis
Share this live IRMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (IRMD)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Mar 26, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish sentiment towards $IRMD, with one user expressing optimism about the stock's potential following a perceived technical signal. No recent news articles were available.
Key Retail Themes:
Technical Analysis
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 43 HOLD |
Advanced IRMD Option Strategies
Professional options setups generated by AI based on today's IRMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive IRMD Research Pages
